A药品名称: B药品名称: B与A对换
 药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
A药品
B药品
详细
Bimatoprost
Dotarizine
The risk or severity of adverse effects can be increased when Dotarizine is combined with Acenocoumarol.
Bimatoprost
Sertindole
The risk or severity of adverse effects can be increased when Sertindole is combined with Acenocoumarol.
Bimatoprost
Cariprazine
The risk or severity of adverse effects can be increased when Cariprazine is combined with Acenocoumarol.
Bimatoprost
Rotigotine
The risk or severity of adverse effects can be increased when Rotigotine is combined with Acenocoumarol.
Bimatoprost
Iloperidone
The risk or severity of adverse effects can be increased when Iloperidone is combined with Acenocoumarol.
Bimatoprost
Flibanserin
The risk or severity of adverse effects can be increased when Flibanserin is combined with Acenocoumarol.
Bimatoprost
Fluspirilene
The risk or severity of adverse effects can be increased when Fluspirilene is combined with Acenocoumarol.
Bimatoprost
Lysergic acid diethylamide
The risk or severity of adverse effects can be increased when Lysergic acid diethylamide is combined with Acenocoumarol.
Bimatoprost
Yohimbine
The risk or severity of adverse effects can be increased when Yohimbine is combined with Acenocoumarol.
Bimatoprost
Aripiprazole
The risk or severity of adverse effects can be increased when Aripiprazole is combined with Acenocoumarol.
Bimatoprost
Ergoloid mesylate
The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Acenocoumarol.
Bimatoprost
Almotriptan
The risk or severity of adverse effects can be increased when Almotriptan is combined with Acenocoumarol.
Bimatoprost
Lithium citrate
The risk or severity of adverse effects can be increased when Lithium citrate is combined with Acenocoumarol.
Bimatoprost
Solriamfetol
The risk or severity of adverse effects can be increased when Solriamfetol is combined with Acenocoumarol.
Bimatoprost
Lithium carbonate
The risk or severity of adverse effects can be increased when Lithium carbonate is combined with Acenocoumarol.
Bimatoprost
5-methoxy-N,N-dimethyltryptamine
The risk or severity of adverse effects can be increased when 5-methoxy-N,N-dimethyltryptamine is combined with Acenocoumarol.
Bimatoprost
N-(2-hydroxybenzyl)-2,5-dimethoxy-4-cyanophenylethylamine
The risk or severity of adverse effects can be increased when N-(2-hydroxybenzyl)-2,5-dimethoxy-4-cyanophenylethylamine is combined with Acenocoumarol.
Bimatoprost
2,5-Dimethoxy-4-ethylthioamphetamine
The risk or severity of adverse effects can be increased when 2,5-Dimethoxy-4-ethylthioamphetamine is combined with Acenocoumarol.
Bimatoprost
Imipramine oxide
The risk or severity of adverse effects can be increased when Imipramine oxide is combined with Acenocoumarol.
Bimatoprost
Naftidrofuryl
The risk or severity of adverse effects can be increased when Naftidrofuryl is combined with Acenocoumarol.
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究  客服热线:0575-83552251 / 13754370441  QQ客服:药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证:浙B2-20220931 互联网药品信息服务资格证书编号:(浙)-经营性2023-0215 浙公网安备:330683240604819103159
 医药代理商群1:药药网药品采购交流医药代理商群2:药药网药品采购交流2医药代理商群3:药药网药品采购交流3